Psychiatry and Neurology, Neurology · Lubbock, TX
NPI
1831484831
Since 2011
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
3506 21st St, Suite 400
Lubbock, TX, 79410
Phone (806) 725-4115
Groups this clinician bills Medicare through
Medicare paid, 2024
$172K
13,768 services
Medicare patients, 2024
596
Average age 75
Drug cost, 2024
$2.8M
4,503 prescriptions
Company payments, 2025
$43K
From 27 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Katie L Hendley was code J0585 (injection, onabotulinumtoxina, 1 unit), 5,500 times for 14 patients. In total Katie L Hendley billed 13,768 services in 33 codes, and Medicare paid $172K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-09-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 5,500 | 14 | $4.82 | $27K |
| J0586 Injection, abobotulinumtoxina, 5 units | Office | 4,910 | 11 | $6.82 | $33K |
| J0588 Injection, incobotulinumtoxin a, 1 unit | Office | 1,390 | 11 | $4.18 | $5,808 |
| 99214 Office E&M - Established | Office | 394 | 272 | $87.14 | $34K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 346 | 236 | $11.45 | $3,960 |
| 99232 Hospital E&M - Subsequent | Facility | 159 | 108 | $59.11 | $9,398 |
| 99213 Office E&M - Established | Office | 93 | 83 | $54.42 | $5,061 |
| 99222 Hospital E&M - Initial | Facility | 90 | 89 | $97.07 | $8,737 |
| 64616 Musculoskeletal | Office | 45 | 13 | $157.61 | $7,093 |
| 99215 Office E&M - Established | Office | 43 | 38 | $127.60 | $5,487 |
| 99214 Office E&M - Established | Facility | 41 | 37 | $70.04 | $2,872 |
| 99205 Office E&M - New | Facility | 38 | 38 | $130.04 | $4,942 |
| 99204 Office E&M - New | Office | 33 | 33 | $123.31 | $4,069 |
| 64612 Musculoskeletal | Office | 32 | 11 | $131.10 | $4,195 |
| 95983 Electrical Nerve Conductivity | Office | 30 | 21 | $34.08 | $1,022 |
By year: 2022 $189K for 16,194 services; 2023 $180K for 13,798 services; 2024 $172K for 13,768 services.
Medicare prescription drug claims, 2024
In 2024, the drug Katie L Hendley prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 1,163 prescriptions and refills. In total Katie L Hendley wrote 4,503 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 1,163 | 2,938 | 302 | $42K |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 357 | 889 | 98 | $11K |
| Clonazepam Generic | 236 | 342 | 36 | $1,244 |
| Rytary Carbidopa/Levodopa | 225 | 444 | 49 | $269K |
| Primidone Generic | 204 | 529 | 52 | $11K |
| Rasagiline Mesylate Generic | 174 | 477 | 53 | $35K |
| Xadago Safinamide Mesylate | 153 | 219 | 22 | $242K |
| Gabapentin Generic | 142 | 309 | 38 | $2,466 |
| Gocovri Amantadine Hcl | 131 | 173 | 20 | $366K |
| Memantine Hcl Generic | 126 | 272 | 30 | $3,048 |
| Quetiapine Fumarate Generic | 115 | 205 | 23 | $2,505 |
| Donepezil Hcl Generic | 112 | 272 | 27 | $1,346 |
| Citalopram Hbr Citalopram Hydrobromide | 98 | 213 | 24 | $833 |
| Escitalopram Oxalate Generic | 94 | 232 | 23 | $1,589 |
| Amantadine Amantadine Hcl | 80 | 202 | 26 | $4,314 |
Brand drugs: 987 claims; generic drugs: 3,516 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Katie L Hendley $43K ($43K in general payments such as food, travel and fees) from 27 companies. The largest payer was Abbvie Inc. with $26K.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 59 | $26K |
| MDD US Operations, LLC | 14 | $9,324 |
| Teva Pharmaceuticals USA, Inc. TEVA | 22 | $5,339 |
| Medtronic, Inc. MDT | 29 | $456 |
| Merz Pharmaceuticals, LLC | 5 | $225 |
| Eisai Inc. 4523.T | 8 | $201 |
| Alexion Pharmaceuticals, Inc. AZN | 4 | $129 |
| Neurocrine BioSciences, Inc. NBIX | 4 | $95.32 |
| Argenx US, Inc. ARGX | 4 | $82.26 |
| UCB, Inc. UCB.BR | 3 | $79.2 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.